<DOC>
	<DOCNO>NCT02271282</DOCNO>
	<brief_summary>Repletion testosterone ( Te ) old men drive GH secretion aromatization estradiol ( E2 ) , act via estrogen receptor ( ER ) . Conversely , postulate estrogen deprivation postmenopausal woman attenuate growth hormone ( GH ) secretion insulin-like growth factor-1 ( IGF-I ) production , thus favor development metabolic syndrome men treat toremifene , new estrogen antagonist use adjunctively prostatic cancer</brief_summary>
	<brief_title>Estradiol-Receptor Blockade Older Men Women</brief_title>
	<detailed_description>Systemic concentration Te , E2 , GH , IGF-I insulin growth factor bind protein 3 ( IGFBP-3 ) decline healthy age men woman . Relative sex-steroid deprivation accentuate GH IGF-I depletion , since Te stimulate GH IGF-I production old men , hypogonadal male age , patient undergo ( genotypic female-to-male ) gender reassignment . The estrogen-receptor antagonist , tamoxifen , block effect Te , suggest involvement E2 GH 's stimulation least young men . E2 alone stimulate GH secretion young old woman . Because Te convert E2 aromatization body , postulate E2 active moiety men woman . Moreover , hypothesize decline E2 old men woman contributes fall GH output . These basic concept test .</detailed_description>
	<mesh_term>Toremifene</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>Inclusion : 1 . 40 healthy woman men ( age 50 80 ) ; woman postmenopausal ( clinically define E2 &lt; 50 pg/mL , FSH &gt; 30Iu/L ) 2 . BMI 1835 kg/m2 3. community dwelling ; voluntarily consent Exclusion : 1. recent use psychotropic neuroactive drug ( within five biological halflive ) ; 2. obesity ( outside weight range ) ; 3 . Laboratory test result deem physician acceptable , viz potassium &lt; 3.5 mEq/L , magnesium &lt; 1.5 mEq/L , triglycerides &gt; 300 , BUN &gt; 30 creatinine &gt; 1.5 mg/dL , liver function test twice upper limit normal , anemia ( hemoglobin must meet Blood Bank requirement Hgb â‰¥ 12.5 g/dL ) 4. drug alcohol abuse , psychosis , depression , mania severe anxiety ; 5. acute chronic organsystem disease , include renal failure ( creatinine &gt; 1.5 mg/dL ) 6. endocrinopathy , primary thyroidal failure receive replacement 7. nightshift work recent transmeridian travel ( exceed 3 time zone within 7 day admission ) , 8. acute weight change ( loss gain &gt; 2 kg 6 week ) ; 9. allergy toremifene 10. unwillingness provide write informed consent . 11 . PSA &gt; 4.0 ng/mL men 12 . History suspicion prostatic disease ( elevated PSA , indeterminate nodule mass , obstructive uropathy , breast cancer ) , 13 . Other carcinoma ( exclude localize basal cell carcinoma remove surgically treat recurrence ) . 14 . History thrombotic arterial disease ( stroke , TIA , MI , angina ) deep vein thrombophlebitis . 15 . History CHF , cardiac arrhythmia , congenital QT prolongation , medication use treat cardiac arrhythmia strong CYP3A4 inhibitor .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>